Asthma management in five European countries: Doctors' knowledge, attitudes and prescribing behaviour

European Respiratory Journal

Volumn 15, Issue 1, 2000, Pages 25-29

  Lagerlov P ^b   Veninga, C C M ^c   Muskova, M ^c   Hummers Pradier, E ^c   Stalsby Lundborg C ^c   Andrew, M ^a   Haaijer Ruskamp, F M ^c  

^a Helsetilsynet i Oslo og Akershus   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NONE

Author keywords

Asthma; Attitudes; Knowledge; Prescribing

Indexed keywords

ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; XANTHINE DERIVATIVE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; BACTERIAL INFECTION; BRONCHODILATATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DOSE RESPONSE; GERMANY; HUMAN; NETHERLANDS; NORMAL HUMAN; NORWAY; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; SLOVAKIA; SWEDEN;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; ATTITUDE OF HEALTH PERSONNEL; CROSS-CULTURAL COMPARISON; DRUG UTILIZATION; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG;

EID: 0033959711     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15a06.x     Document Type: Article

References (22)

1. Holgate ST. The cellular and mediator basis of asthma in relation tonatural history. Lancet 1997; 350 (Suppl. II): 5-9.
2. Kemp JP. Approaches to Asthma Management. Realities and Recommendations. Arch Intern Med 1993; 153: 805-812.
3. British Thoracic Society, British Paediatric Association, Royal College of Physicians, King's Fund Centre, National Asthma Campaign, Royal College of General Practitioners, General Practitioners in Asthma Group, British Association of Accident and Emergency Medicine, British Paediatric Respiratory Group. Guidelines on the management of asthma. Thorax 1993; 48: S1-24.
4. Bottema BJAM, Fabels EJ, Van Grusven PM, et al. Dutch College of General Practitioners - Guideline Adults with Chronic Non-specific Lung Diseases; Diagnosis. Huisarts Wet 1992; 35: 430-436.
5. Van der Waart MAC, Dekker FW, Nijhoff S, et al. Dutch College of General Practitioners - Guideline Adults with Chronic Non-specific Lung Diseases; Treatment. Huisarts Wet 1992; 35: 437-443.
6. Norwegian Drug and Therapeutic Formulary 1994-95. Vennerød Am, ed. Oslo, Norsk Legemiddelhåndbok I/S, 1994; pp. 469-482.
7. Wettengel R, Berdel D, Cegla U, et al. Recommendation of the German Respiratory Tract League on asthma management of adults and children. The German Respiratory Tract League. Med Klin 1994; 15; 89(2): 57-67.
8. Kristufec P, Hruskovic I. National guidelines for optimal diagnosis and management of asthma in Slovak republic. The Slovak Medical Society in Bratislava, Slovakia 1996.
9. Medical Products Agency. Workshop: Pharmacological Treatment of Bronchial Asthma (1993:1). Uppsala, Medical Products Agency, 1993.
10. Veninga CCM, Lagerløv P, Wahlstrøm R, et al. Evaluating an educational intervention to improve the treatment of asthma in four European countries. Am J Respir Crit Care Med 1999; 160: 1254-1262.
11. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaboration Centre for Drug Statistics Methodology, 1994.
12. Marshall T. Scientific knowledge in medicine: a new clinical epistemology? J Eval Clin Pract 1997; 3: 133-138.
13. Jans MP, Shellevis FG, Van Hensbergen W, Van Emden TD, Van Eijk JTM. Management of asthma and COPD patients: feasibility of the application of guidelines in general practice. Int J Qual Health Care 1998; 10: 27-34.
14. Kimbel KH. Drug prescribing patterns in Europe. Int J Clin Pharmacol Ther Toxicol 1992; 30: 459-461.
15. Taylor D. Prescribing in Europe-forces for change. BMJ 1992; 304: 239-242.
16. Naish J, Sturdy P, Toon P. Appropriate prescribing in asthma and its related cost in east London. BMJ 1995; 310: 97-100.
17. Janson C, Chinn S, Javis PB. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J 1997; 10: 1795-1802.
18. Nilsson JL, Johansson H, Wennberg M. Large differences between prescribed and dispensed medicine could indicate undertreatment. Drug Information J 1995; 25: 1243-1246.
19. Hallas J, Hansen N-C G. Individual utilization of antiasthma medication by young adults: a prescription database analysis. J Intern Med 1993; 234: 65-70.
20. Vermeire P. Difference in asthma management around the world. Eur Respir Rev 1994; 4: 21, 279-281.
21. Keeley D, Rees J. New guidelines on asthma management. BMJ 1997; 314: 315-316.
22. Bone RC. Another word of caution regarding a new long-acting bronchodilator. JAMA 1995; 273: 967-968.